Evidence map›Paper›PMID 42605179›Full record

ArticleSmall methods2026

Filtration-Based SERS With In Situ Gold Growth in Bacterial Microenvironment for Rapid Detection of Low-Level Bacteria.

Eun-Bi Jang, Ji Young Lee, Hoeil Chung, Min-Young Lee

Abstract read
In one paragraph

Article in Small methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eun-Bi JangAdvanced Bio and Healthcare Materials Research Division, Korea Institute of Materials Science (KIMS), Changwon, Gyeongnam, Republic of Korea.
Ji Young LeeAdvanced Bio and Healthcare Materials Research Division, Korea Institute of Materials Science (KIMS), Changwon, Gyeongnam, Republic of Korea.
Hoeil ChungDepartment of Chemistry and Research Institute for Convergence of Basic Science, Hanyang University, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0003-0129-6571
Min-Young LeeAdvanced Bio and Healthcare Materials Research Division, Korea Institute of Materials Science (KIMS), Changwon, Gyeongnam, Republic of Korea.

Funding

Fundamental Research Program PNKB010Korea Institute of Materials ScienceMinistry of Trade, Industry & EnergyNational Research Council of Science & Technology GTL25062-000Technology Innovation Program RS-2024-00432381
6 · The paper itself

Abstract

Rapid bacterial detection and timely antimicrobial susceptibility assessment are essential for effective infection management, yet remain challenging under clinically relevant low-concentration conditions. Here, we present a filtration-based surface-enhanced Raman scattering (SERS) platform based on a microenvironment engineering strategy, in which plasmonic nanostructures are dynamically formed within the bacterial microenvironment. Using a gold nanostructured glass microfiber membrane, the platform enables large-volume sample processing through size-selective bacterial capture, followed by in situ gold growth that generates bacteria-centered plasmonic hotspots directly around bacterial cells. This architecture fundamentally overcomes the intrinsic hotspot-bacteria mismatch in conventional substrate-based SERS systems, enabling highly sensitive and selective detection while effectively suppressing nonspecific interference in complex biological matrices. To further address sampling limitations at low concentrations, a minimal pre-culture strategy was introduced to enhance bacterial surface occupancy, improving the detection limit from 10

Indexed as

BacteriaFiltrationGoldSpectrum Analysis, RamanAnti-Bacterial AgentsMetal NanoparticlesAnti-Bacterial AgentsGoldbacterial microenvironmentfiltration‐based detectionin situ gold growthlow‐level detectionrapid antimicrobial susceptibility testingsurface‐enhanced Raman scattering

Identifiers

PMID42605179
PMCPMC13646021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.